BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Confirms Approach to Sofdra NDA Resubmission, page-22

  1. 542 Posts.
    lightbulb Created with Sketch. 90
    Today's announcement reads; "....likely 6 months review process."
    Sounds like management thinks it's flexible!!
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.